At a glance
ClinicalIndex Comparison RecordN/ACompleted· 124 enrolled
Drug / intervention
Insulin Pumpdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Safety Evaluation of the Hybrid Closed Loop (HCL) System in Type 1 Diabetes
In Brief
A clinical study evaluating Insulin Pump for Type 1 Diabetes. Completed, enrolled 124 participants across 10 sites in 2 countries.
Detailed Summary
This study is a single-arm, multi-center, Home and Hotel Clinical Investigation in subjects with type 1 diabetes on insulin pump therapy. The purpose of this study is to demonstrate that the closed loop algorithm that is built into the 670G insulin pump is safe as part of the overall system.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 1 Diabetes
CountriesIsrael, United States
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartJun 2015
First PostedJun 2015
Primary CompletionMar 2016
Study CompletionOct 2018
TodayJul 2026
First PostedJun 4, 2015
Enrollment StartJun 1, 2015
Primary CompletionMar 1, 2016
Study CompletionOct 1, 2018
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 11.1 years ago
Interventions
Insulin Pumpdevice
Closed Loop Algorithm